Study Finds LSD Therapy Strikingly Effective at Reducing Anxiety and Depression

According to new research, psychedelic-assisted therapy may be an effective and long- lasting treatment for anxiety and depression.

In a new study published in the journal Biological Psychiatry, a team of Swiss researchers administered 20 participants, who were diagnosed with a life threatening illness, and a further 22 participants with a mental disorder, significant amounts of lysergic acid diethylamide.

The results seem to have been better than the researchers thought.

The response was sustained according to the study co-author.

The pilot study found that LSD could reduce anxiety in people with life threatening illnesses.

Liechti told Psy Post that they wanted to confirm a pilot study on the effects of LSD in patients with anxiety and life threatening illness. We wanted to explore the benefits of therapy for patients with an anxiety disorder.

There is a growing field of research into the use of drugs that are considered to be hallucinogens. The hallucinogenic substance in magic mushrooms is being investigated to see if it can be used to treat depression.

Liechti said that they wanted to use a different type of drug to broaden the field.

The participants in the study were given either a placebo or a drug. The people who received the drug were given 200 micrograms, the top end of the range.

The researchers say that LSD produced strong reductions of anxiety, depression, and general psychiatric symptomatology compared with placebo in the first treatment period. The effects were sustained for up to 16 weeks.

There are inherent risks to a study like this. According to the paper, the team observed nine serious adverse events, six of which occurred during the LSD period and three of which occurred during the placebo period.

Liechti told Psy Post that one patient had to be kept overnight and discharged in the morning.

The fact that patients had no issues figuring out if they were given a placebo or a drug is a good sign.

It remains to be shown whether blinding can be improved with these active placebo approaches and valid blinding remains a challenge in many other clinical trials.

The widespread use of drugs for therapeutic purposes is still a long way off.

Larger trials are needed to confirm the findings according to the paper.

According to a new research, LSD-assisted therapy causes rapid and lasting reductions in anxiety and depression.

There is growing evidence that LSD improves learning and memory.